Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 31 Oct 2024 14:48 CET |
FDJ | FDJ: Conclusion of the European Commission's investigation | 40501020 Casinos and Gambling | Legal |
| 31 Oct 2024 14:48 CET |
FDJ | FDJ : Conclusion de l’enquête de la Commission européenne | 40501020 Casinos and Gambling | Legal |
| 31 Oct 2024 12:00 CET |
SEGRO PUBLIC LIMITED COMPANY | Total Voting Rights | 35102020 Industrial REITs | Legal |
| 31 Oct 2024 11:45 CET |
INMARK PRIME SOCIMI | Dividend Distribution Oct 2024 | 35102030 Office REITs | Dividend |
| 31 Oct 2024 08:30 CET |
NANOBIOTIX | NANOBIOTIX participera à plusieurs conférences investisseurs en novembre | 20103010 Biotechnology | Meetings / events |
| 31 Oct 2024 08:30 CET |
NANOBIOTIX | NANOBIOTIX to Participate in Multiple Investor Conferences in November | 20103010 Biotechnology | Meetings / events |
| 31 Oct 2024 08:22 CET |
TOTALENERGIES | TotalEnergies Announces the Third Interim Dividend of €0.79/Share for Fiscal Year 2024, an Increase Close to 7% Compared to 2023 | 60101000 Integrated Oil and Gas | Dividend |
| 31 Oct 2024 08:22 CET |
TOTALENERGIES | TotalEnergies annonce le troisième acompte sur dividende de 0,79 €/action au titre de l’exercice 2024, en hausse de près de 7% par rapport à 2023 | 60101000 Integrated Oil and Gas | Dividend |
| 31 Oct 2024 08:20 CET |
TOTALENERGIES | TotalEnergies SE: Third Quarter 2024 Results | 60101000 Integrated Oil and Gas | Commercial results |
| 31 Oct 2024 08:20 CET |
TOTALENERGIES | TotalEnergies SE : Résultats du troisième trimestre 2024 | 60101000 Integrated Oil and Gas | Commercial results |
| 31 Oct 2024 08:10 CET |
TME PHARMA | TME PHARMA REÇOIT UNE SUBVENTION FÉDÉRALE ALLEMANDE DE 2,4 MILLIONS D'EUROS POUR SOUTENIR L'ESSAI DE PHASE 2 DE NOX-A12 DANS LE CANCER DU CERVEAU | 20103010 Biotechnology | Other subject |
| 31 Oct 2024 08:10 CET |
TME PHARMA | TME Pharma Awarded €2.4 Million German Federal Grant to Support NOX-A12 Phase 2 Trial in Brain Cancer | 20103010 Biotechnology | Other subject |
| 31 Oct 2024 08:00 CET |
AMA CORPORATION PLC | AMA : Résultats du 1er semestre 2024 / Chiffre d’affaires du 3ème trimestre 2024 | 50205020 Professional Business Support Services | General meeting / Board Meeting |
| 31 Oct 2024 08:00 CET |
CREDIT AGRICOLE | CREDIT AGRICOLE SA : Crédit Agricole Leasing & Factoring accélère le développement de son activité en Allemagne et annonce avoir conclu un accord en vue d’acquérir Merca Leasing | 30101010 Banks | Other subject |
| 31 Oct 2024 08:00 CET |
AgroGeneration | RÉALISATION DE L'ACQUISITION D'UN BLOC MAJORITAIRE D'ACTIONS AGROGENERATION | 45102010 Farming, Fishing, Ranching and Plantations | Alliances and agreements, Mergers, Acquiqitions, Transferts |
| 31 Oct 2024 08:00 CET |
AgroGeneration | First Half 2024 Financial Results and Latest Operational Update | 45102010 Farming, Fishing, Ranching and Plantations | Sales, Income, Commercial results |
| 31 Oct 2024 08:00 CET |
AMA CORPORATION PLC | AMA: 2024 half-year earnings / 2024 third-quarter revenues | 50205020 Professional Business Support Services | General meeting / Board Meeting |
| 31 Oct 2024 08:00 CET |
AMA CORPORATION PLC | AMA : RAPPORT FINANCIER SEMESTRIEL 2024 | 50205020 Professional Business Support Services | Corporate life |
| 31 Oct 2024 08:00 CET |
NOVACYT | Changement au Conseil d'Administration | 20102010 Medical Equipment | Legal |
| 31 Oct 2024 08:00 CET |
CREDIT AGRICOLE | CREDIT AGRICOLE SA: Crédit Agricole Leasing & Factoring accelerates the development of its business in Germany, and announces the signing of an agreement to acquire Merca Leasing | 30101010 Banks | Other subject |
| 31 Oct 2024 08:00 CET |
AgroGeneration | FINALIZATION OF ACQUISITION OF A CONTROLLING STAKE IN AGROGENERATION | 45102010 Farming, Fishing, Ranching and Plantations | Alliances and agreements, Mergers, Acquiqitions, Transferts |
| 31 Oct 2024 08:00 CET |
AgroGeneration | Résultats semestriels 2024 et point sur les activités opérationnelles | 45102010 Farming, Fishing, Ranching and Plantations | Sales, Income, Commercial results |
| 31 Oct 2024 07:30 CET |
AYVENS | Robust Q3 & 9M 2024 Results(1) - Integration on track | 40201040 Rental and Leasing Services: Consumer | Other subject |
| 31 Oct 2024 07:30 CET |
TECHNIP ENERGIES N.V. | Technip Energies Financial Results for the First Nine Months of 2024 | 60101030 Oil Equipment and Services | Commercial results |
| 31 Oct 2024 07:30 CET |
TECHNIP ENERGIES N.V. | Résultats Financiers de Technip Energies des Neuf Premiers Mois 2024 | 60101030 Oil Equipment and Services | Commercial results |
| 31 Oct 2024 07:00 CET |
SOPRA STERIA GROUP | Sopra Steria : Le chiffre d’affaires du 3ème trimestre 2024 résiste à 1 356,9 M€ | 10101010 Computer Services | Other subject |
| 31 Oct 2024 07:00 CET |
STMICROELECTRONICS | STMicroelectronics annonce ses résultats financiers du troisième trimestre 2024 | 10102010 Semiconductors | Commercial results |
| 31 Oct 2024 07:00 CET |
RUBIS | RUBIS: Rubis révise ses perspectives financières pour 2024 | 40401030 Specialty Retailers | Income |
| 31 Oct 2024 07:00 CET |
CHARGEURS | CHARGEURS - L’exposition PIXELS dédiée à Miguel Chevalier, qui démarre le 5 novembre, ouvre le Grand Palais Immersif à l’art du XXIème siècle | 50203000 Diversified Industrials | Legal |
| 31 Oct 2024 07:00 CET |
SOPRA STERIA GROUP | Sopra Steria Group: Revenue for Q3 2024 Resilient at €1,356.9 Million | 10101010 Computer Services | Other subject |
| 31 Oct 2024 07:00 CET |
STMICROELECTRONICS | STMicroelectronics Reports 2024 Third Quarter Financial Results | 10102010 Semiconductors | Commercial results |
| 31 Oct 2024 07:00 CET |
RUBIS | RUBIS: Rubis revises 2024 financial guidance | 40401030 Specialty Retailers | Income |
| 31 Oct 2024 07:00 CET |
CHARGEURS | CHARGEURS - The PIXELS exhibition featuring Miguel Chevalier, opening on November 5, brings the Grand Palais Immersif into 21st-century Art | 50203000 Diversified Industrials | Legal |
| 31 Oct 2024 06:56 CET |
SPIE | SPIE - Press release - Quarterly information as at September 30th, 2024 | 50101015 Engineering and Contracting Services | Income |
| 31 Oct 2024 06:56 CET |
SPIE | SPIE - Communiqué de presse - Information trimestrielle au 30 septembre 2024 | 50101015 Engineering and Contracting Services | Income |
| 31 Oct 2024 06:55 CET |
PLUXEE N.V. | Pluxee Fiscal 2024 Results | 50205015 Transaction Processing Services | Other subject |
| 31 Oct 2024 06:55 CET |
PLUXEE N.V. | Résultats de l’exercice 2024 | 50205015 Transaction Processing Services | Other subject |
| 31 Oct 2024 06:35 CET |
SOCIETE GENERALE | Societe Generale: Managerial changes within the Group | 30101010 Banks | - |
| 31 Oct 2024 06:35 CET |
SOCIETE GENERALE | Société Générale : Evolutions managériales au sein du Groupe | 30101010 Banks | - |
| 31 Oct 2024 06:25 CET |
SOCIETE GENERALE | Societe Generale: Third quarter 2024 earnings | 30101010 Banks | Income |
| 31 Oct 2024 06:25 CET |
SOCIETE GENERALE | Société Générale : Résultats du troisième trimestre 2024 | 30101010 Banks | Income |
| 30 Oct 2024 23:20 CET |
PAREF | PAREF - FINANCIAL INFORMATION AS AT SEPTEMBER 30, 2024 | 35102030 Office REITs | Sales, Income |
| 30 Oct 2024 23:00 CET |
PAREF | PAREF - INFORMATIONS FINANCIÈRES AU TROISIEME TRIMESTRE 2024 | 35102030 Office REITs | Sales, Income |
| 30 Oct 2024 22:25 CET |
METAVISIO (THOMSON COMPUTING) | RESULTATS SEMESTRIELS 2024 _ Activité et résultats solides et Stratégie à l'international affirmée | 10102030 Computer Hardware | Sales, Income, Commercial results |
| 30 Oct 2024 21:30 CET |
CELLECTIS | Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024 | 20103010 Biotechnology | - |
| 30 Oct 2024 21:30 CET |
CELLECTIS | Cellectis publiera ses résultats financiers du troisième trimestre 2024 le 4 novembre 2024 | 20103010 Biotechnology | - |
| 30 Oct 2024 21:00 CET |
INVENTIVA | Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH | 20103010 Biotechnology | Other subject |
| 30 Oct 2024 21:00 CET |
INVENTIVA | Inventiva annonce la recommandation positive du cinquième DMC de l’étude clinique NATiV3 Phase 3 avec lanifibranor dans la MASH | 20103010 Biotechnology | Other subject |
| 30 Oct 2024 20:00 CET |
CLARANOVA | Claranova: Combined Annual Ordinary and Extraordinary General Meeting of December 4, 2024 | 10101015 Software | General meeting / Board Meeting |
| 30 Oct 2024 20:00 CET |
CLARANOVA | Claranova : Assemblée Générale Annuelle Ordinaire et Extraordinaire du 4 décembre 2024 | 10101015 Software | General meeting / Board Meeting |